Immutep Limited
PRRUF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -69.9% | 81.8% | -18% | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | -1,802.8% | -704.7% | -1,119.4% | 52.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,924.1% | -838.5% | -1,290.8% | -1,051.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2,059.8% | -710.9% | -1,241.3% | -1,005.7% |
| EPS Diluted | -0.013 | -0.015 | -0.018 | -0.018 |
| % Growth | 13% | 13% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |